img

Global Acquired hemophilia A Treatment Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Acquired hemophilia A Treatment Market Research Report 2024

ELOCTATE, a therapy regimen for the treatment of hemophilia A that uses Fc Fusion to keep Factor VIII circulating in your bloodstream longer.
According to Mr Accuracy reports new survey, global Acquired hemophilia A Treatment market is projected to reach US$ 996.1 million in 2029, increasing from US$ 1245 million in 2022, with the CAGR of -3.2% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Acquired hemophilia A Treatment market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Acquired hemophilia A Treatment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Sanofi
Sobi
Segment by Type
200IU
250IU

Segment by Application


Hospital
Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Acquired hemophilia A Treatment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acquired hemophilia A Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 200IU
1.2.3 250IU
1.3 Market by Application
1.3.1 Global Acquired hemophilia A Treatment Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Acquired hemophilia A Treatment Market Perspective (2018-2029)
2.2 Acquired hemophilia A Treatment Growth Trends by Region
2.2.1 Global Acquired hemophilia A Treatment Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Acquired hemophilia A Treatment Historic Market Size by Region (2018-2024)
2.2.3 Acquired hemophilia A Treatment Forecasted Market Size by Region (2024-2029)
2.3 Acquired hemophilia A Treatment Market Dynamics
2.3.1 Acquired hemophilia A Treatment Industry Trends
2.3.2 Acquired hemophilia A Treatment Market Drivers
2.3.3 Acquired hemophilia A Treatment Market Challenges
2.3.4 Acquired hemophilia A Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acquired hemophilia A Treatment Players by Revenue
3.1.1 Global Top Acquired hemophilia A Treatment Players by Revenue (2018-2024)
3.1.2 Global Acquired hemophilia A Treatment Revenue Market Share by Players (2018-2024)
3.2 Global Acquired hemophilia A Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Acquired hemophilia A Treatment Revenue
3.4 Global Acquired hemophilia A Treatment Market Concentration Ratio
3.4.1 Global Acquired hemophilia A Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acquired hemophilia A Treatment Revenue in 2022
3.5 Acquired hemophilia A Treatment Key Players Head office and Area Served
3.6 Key Players Acquired hemophilia A Treatment Product Solution and Service
3.7 Date of Enter into Acquired hemophilia A Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acquired hemophilia A Treatment Breakdown Data by Type
4.1 Global Acquired hemophilia A Treatment Historic Market Size by Type (2018-2024)
4.2 Global Acquired hemophilia A Treatment Forecasted Market Size by Type (2024-2029)
5 Acquired hemophilia A Treatment Breakdown Data by Application
5.1 Global Acquired hemophilia A Treatment Historic Market Size by Application (2018-2024)
5.2 Global Acquired hemophilia A Treatment Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Acquired hemophilia A Treatment Market Size (2018-2029)
6.2 North America Acquired hemophilia A Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Acquired hemophilia A Treatment Market Size by Country (2018-2024)
6.4 North America Acquired hemophilia A Treatment Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Acquired hemophilia A Treatment Market Size (2018-2029)
7.2 Europe Acquired hemophilia A Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Acquired hemophilia A Treatment Market Size by Country (2018-2024)
7.4 Europe Acquired hemophilia A Treatment Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Acquired hemophilia A Treatment Market Size (2018-2029)
8.2 Asia-Pacific Acquired hemophilia A Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Acquired hemophilia A Treatment Market Size by Region (2018-2024)
8.4 Asia-Pacific Acquired hemophilia A Treatment Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Acquired hemophilia A Treatment Market Size (2018-2029)
9.2 Latin America Acquired hemophilia A Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Acquired hemophilia A Treatment Market Size by Country (2018-2024)
9.4 Latin America Acquired hemophilia A Treatment Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acquired hemophilia A Treatment Market Size (2018-2029)
10.2 Middle East & Africa Acquired hemophilia A Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Acquired hemophilia A Treatment Market Size by Country (2018-2024)
10.4 Middle East & Africa Acquired hemophilia A Treatment Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Sanofi
11.1.1 Sanofi Company Detail
11.1.2 Sanofi Business Overview
11.1.3 Sanofi Acquired hemophilia A Treatment Introduction
11.1.4 Sanofi Revenue in Acquired hemophilia A Treatment Business (2018-2024)
11.1.5 Sanofi Recent Development
11.2 Sobi
11.2.1 Sobi Company Detail
11.2.2 Sobi Business Overview
11.2.3 Sobi Acquired hemophilia A Treatment Introduction
11.2.4 Sobi Revenue in Acquired hemophilia A Treatment Business (2018-2024)
11.2.5 Sobi Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Acquired hemophilia A Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of 200IU
Table 3. Key Players of 250IU
Table 4. Global Acquired hemophilia A Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Acquired hemophilia A Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Acquired hemophilia A Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Acquired hemophilia A Treatment Market Share by Region (2018-2024)
Table 8. Global Acquired hemophilia A Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Acquired hemophilia A Treatment Market Share by Region (2024-2029)
Table 10. Acquired hemophilia A Treatment Market Trends
Table 11. Acquired hemophilia A Treatment Market Drivers
Table 12. Acquired hemophilia A Treatment Market Challenges
Table 13. Acquired hemophilia A Treatment Market Restraints
Table 14. Global Acquired hemophilia A Treatment Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Acquired hemophilia A Treatment Market Share by Players (2018-2024)
Table 16. Global Top Acquired hemophilia A Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired hemophilia A Treatment as of 2022)
Table 17. Ranking of Global Top Acquired hemophilia A Treatment Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Acquired hemophilia A Treatment Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acquired hemophilia A Treatment Product Solution and Service
Table 21. Date of Enter into Acquired hemophilia A Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acquired hemophilia A Treatment Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Acquired hemophilia A Treatment Revenue Market Share by Type (2018-2024)
Table 25. Global Acquired hemophilia A Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Acquired hemophilia A Treatment Revenue Market Share by Type (2024-2029)
Table 27. Global Acquired hemophilia A Treatment Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Acquired hemophilia A Treatment Revenue Market Share by Application (2018-2024)
Table 29. Global Acquired hemophilia A Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Acquired hemophilia A Treatment Revenue Market Share by Application (2024-2029)
Table 31. North America Acquired hemophilia A Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Acquired hemophilia A Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Acquired hemophilia A Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Acquired hemophilia A Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Acquired hemophilia A Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Acquired hemophilia A Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Acquired hemophilia A Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Acquired hemophilia A Treatment Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Acquired hemophilia A Treatment Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Acquired hemophilia A Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Acquired hemophilia A Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Acquired hemophilia A Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Acquired hemophilia A Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Acquired hemophilia A Treatment Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Acquired hemophilia A Treatment Market Size by Country (2024-2029) & (US$ Million)
Table 46. Sanofi Company Detail
Table 47. Sanofi Business Overview
Table 48. Sanofi Acquired hemophilia A Treatment Product
Table 49. Sanofi Revenue in Acquired hemophilia A Treatment Business (2018-2024) & (US$ Million)
Table 50. Sanofi Recent Development
Table 51. Sobi Company Detail
Table 52. Sobi Business Overview
Table 53. Sobi Acquired hemophilia A Treatment Product
Table 54. Sobi Revenue in Acquired hemophilia A Treatment Business (2018-2024) & (US$ Million)
Table 55. Sobi Recent Development
Table 56. Research Programs/Design for This Report
Table 57. Key Data Information from Secondary Sources
Table 58. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acquired hemophilia A Treatment Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Acquired hemophilia A Treatment Market Share by Type: 2022 VS 2029
Figure 3. 200IU Features
Figure 4. 250IU Features
Figure 5. Global Acquired hemophilia A Treatment Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 6. Global Acquired hemophilia A Treatment Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Pharmacy Case Studies
Figure 9. Acquired hemophilia A Treatment Report Years Considered
Figure 10. Global Acquired hemophilia A Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Acquired hemophilia A Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Acquired hemophilia A Treatment Market Share by Region: 2022 VS 2029
Figure 13. Global Acquired hemophilia A Treatment Market Share by Players in 2022
Figure 14. Global Top Acquired hemophilia A Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acquired hemophilia A Treatment as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Acquired hemophilia A Treatment Revenue in 2022
Figure 16. North America Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Acquired hemophilia A Treatment Market Share by Country (2018-2029)
Figure 18. United States Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Acquired hemophilia A Treatment Market Share by Country (2018-2029)
Figure 22. Germany Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Acquired hemophilia A Treatment Market Share by Region (2018-2029)
Figure 30. China Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Acquired hemophilia A Treatment Market Share by Country (2018-2029)
Figure 38. Mexico Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Acquired hemophilia A Treatment Market Share by Country (2018-2029)
Figure 42. Turkey Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Acquired hemophilia A Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Sanofi Revenue Growth Rate in Acquired hemophilia A Treatment Business (2018-2024)
Figure 45. Sobi Revenue Growth Rate in Acquired hemophilia A Treatment Business (2018-2024)
Figure 46. Bottom-up and Top-down Approaches for This Report
Figure 47. Data Triangulation
Figure 48. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries